Regulatory Expansion Sancilio & Company is actively designing regulatory strategies for US NDAs while pursuing parallel international approvals, including meetings with regulators in Japan, and managing CMC documentation for submissions. This creates opportunities to offer regulatory affairs outsourcing, CMC packaging support, and international submission services.

API Sourcing They source APIs from global manufacturers, indicating a need for reliable supplier qualification, procurement optimization, and compliant supply chain management. Potential sales opportunities include API sourcing services, supplier audits, and vendor management.

In-House Innovation The firm sponsors internal research in fatty acids, lipid bioavailability and Omega Blu nutraceuticals. Opportunities exist to partner on lipid-based formulation development, nutraceutical manufacturing, and clinical evaluation of lipid therapies.

CRO Partnerships Clearway Global operates as a CDMO with a networked development process and is collaborating with global CROs to create international pathways. This points to opportunities in outsourced clinical development, data management, and regulatory strategy partnerships for international programs.

Strategic Fit As a small but growing company with dual lines of business and NDA program management, Sancilio & Company could be an attractive partner for larger players seeking agile, end-to-end development, regulatory, and nutraceutical capabilities, enabling integrated BD collaborations.